Key points are not available for this paper at this time.
Characterizes fecal neutralizing substance post-OPV; leaves open its contribution to mucosal immunity in contemporary vaccine research.
Journal Article STUDIES ON POLIOVIRUS COPROANTIBODY: II. CHARACTERIZATION OF NEUTRALIZING SUBSTANCE IN FECAL EXTRACTS Get access REISAKU KONO, REISAKU KONO Search for other works by this author on: Oxford Academic PubMed Google Scholar SUMI IKAWA, SUMI IKAWA Search for other works by this author on: Oxford Academic PubMed Google Scholar HIDEAKI YAOI, JR., HIDEAKI YAOI, JR. Search for other works by this author on: Oxford Academic PubMed Google Scholar CHUYA HAMADA, CHUYA HAMADA Search for other works by this author on: Oxford Academic PubMed Google Scholar YOSHIMORI ASHIHARA, YOSHIMORI ASHIHARA Search for other works by this author on: Oxford Academic PubMed Google Scholar KATSURO KAWAKAMI KATSURO KAWAKAMI 3Department of Pediatrics, Osaka Medical CollegeTakatsuki, Osaka, Japan Search for other works by this author on: Oxford Academic PubMed Google Scholar American Journal of Epidemiology, Volume 83, Issue 1, January 1966, Pages 14–23, https://doi.org/10.1093/oxfordjournals.aje.a120562 Published: 01 January 1966 Article history Received: 29 July 1964 Published: 01 January 1966
No takes yet. Share an insight, caveat, or question.
Kono et al. (1966) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: